SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...

The test is intended for patients with moderate to severe depression and differentiates between unipolar and bipolar depression.

From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...

Postpartum depression affects some one in eight women in the United States. It typically occurs in the first weeks after childbirth, after a sudden drop in levels of estrogen and progesterone.

Knowable Magazine reports on a new blood test, myLuma, predicting postpartum depression risk with over 80% accuracy, aiding ...

Researchers in the Rady Faculty of Health Sciences are exploring whether a person's genetic risk for depression can help ...

Antidepressant choice or strategy may not alter overall cognition in older adults with treatment-resistant depression, but ...

A recent study has identified a previously unreported risk factor for major depression. The lingering trauma of forced sex.

Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...